Laurence Hurley, PhD, professor, drug discovery, College of Pharmacy Drug Discovery and Development, specializes in the design and development of anti-tumor agents. He started three biotech companies and presently serves as CEO of Reglagene, LLC, which develops small-molecule medicines to fight disease.
Hurley’s published extensively in the area of chemical biology; most recently about targeting transcriptional control through quadruplexes. Named 2017 Arizona Bioscience Researcher of the Year and inducted into the 2007 American Chemical Society Medicinal Chemistry Division Hall of Fame, he received the George and Christine Sosnovsky Award in Cancer Therapy by the ROYAL SOCIETY OF Chemistry among others.
Post-Doctoral Fellow, Chemistry Department, University of British Columbia (Canada), 1972
PhD, Medicinal Chemistry, Purdue University (Indiana), 1970
BPharm, Pharmacy with Honors, Bath University (England), 1967
- Cancer Drugs
- Transcriptional Control
- G and C-quadruoplexes